Trials / Completed
CompletedNCT06202157
Metabolic Differences Between Dihydroberberine and Micellar Berberine
Metabolic Differences Between Dihydroberberine and Micellar Berberine in Humans
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Factors Group of Nutritional Companies Inc. · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Accepted
Summary
Differences in metabolites of dihydroberberine (DHB) and micellar berberine (LipoMicel®, LMB) are investigated through a randomized study involving human volunteers. Over a 24-hour period, blood samples are collected and subjected to Ultra High-Performance Liquid Chromatography-High Resolution Mass Spectrometry (UHPLC-HRMS) analysis to quantify the concentrations of berberine and its metabolites.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | LMB | A baseline blood sample (t=0) is collected from each participant prior to the intervention (LMB), and subsequent blood samples are collected at 0.5, 1, 2, 3, 4, 6, 8, 10, 12, 24 hours post-intervention. |
| OTHER | DHB | A baseline blood sample (t=0) is collected from each participant prior to the intervention (DHB), and subsequent blood samples are collected at 0.5, 1, 2, 3, 4, 6, 8, 10, 12, 24 hours post-intervention. |
Timeline
- Start date
- 2023-04-01
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2024-01-11
- Last updated
- 2024-01-11
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT06202157. Inclusion in this directory is not an endorsement.